Zahra Ghasemi: The Role of Recovered and Source Plasma in Plasma Fractionation
Zahra Ghasemi, Pharmacoeconomist, Member of Health Technology Assessment international and Cochrane, shared a post on LinkedIn:
“It’s International Plasma Awareness Week, and it’s the perfect time to learn something new about plasma: the different ways it’s collected and how it becomes life-saving medicine.
Every Plasma Awareness Week, we say ‘Donate Plasma’, but which plasma?
Plasma reaches fractionation facilities in two ways: recovered and source.
Both can become immunoglobulins, albumin, and clotting factors, but each comes with its own challenges.
That’s why every health system eventually asks:
How much should we rely on each one?
How do we make sure recovered plasma isn’t wasted?
How do we scale up source plasma without compromising donor safety or quality?
So this Plasma Awareness Week, instead of only repeating the slogan, it’s worth learning how these decisions are actually made.
A good place to start is a two-day online workshop running today and tomorrow, hosted by the Iranian Blood Transfusion Organization and the High Institute for Research and Education in Transfusion Medicine, a WHO Collaborating Centre:
‘Optimal Collection and Fractionation of Recovered and Source Plasma.’
October 5–6, 2026 | 07:30–11:00 GMT (11:00–14:30 Tehran time)
Meeting ID: 976 3713 9064 | Passcode: CMS@OCF5
Some of the esteemed speakers include Dr. Ahmad Gharehbaghian, Prof. Albert Farrugia, Dr. Leni von Bonsdorff, Dr. Sedigheh Amini, Dr Mohammad Hessam Rafiee, Dr. Mahtab Maghsudlu, and experts from across Asia, the Middle East, and Europe.”

Other posts featuring Zahra Ghasemi on Hemostasis Today.
-
Nov 21, 2026, 13:06Christine Faressa: Precision PRP and Platelet Biology in Musculoskeletal Care
-
Nov 21, 2026, 13:04Eyad Jamileh: Atrial Fibrillation – Bridging the Global Gaps in Diagnosis and Stroke Prevention
-
Nov 21, 2026, 12:49Thibault Veyron: Optimizing Bivalirudin Treatment in HIT
-
Nov 21, 2026, 12:44Paulus Kirchhof: Left Atrial Appendage Occlusion vs DOACs
-
Nov 21, 2026, 12:19Jiyeon Kim: Human Platelet Lysate – Advancing Cell Therapy and Space Research
-
Nov 21, 2026, 12:13Chaza Alaji: DVT in Early Pregnancy – Why Anticoagulation Decisions Matter
-
Nov 21, 2026, 12:06Salih Ehsan: Why Iron Therapy May Not Work
-
Nov 21, 2026, 11:59Edward Lee Carter: DOACs vs Warfarin for LV Thrombus – Are We Getting Closer to an Answer?
-
Nov 21, 2026, 11:50Abdul Mannan: When G6PD Testing Misleads During Acute Hemolysis